Status:
COMPLETED
Effect of Calcium Chloride on Recovery From Neuromuscular Blockade
Lead Sponsor:
Seoul National University Hospital
Conditions:
Residual Neuromuscular Blockade
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect of calcium chloride against residual neuromuscular blockade at the end of general anesthesia
Detailed Description
During general anesthesia, neuromuscular blocking agent is administered to facilitate endotracheal intubation and the view of operative field. The neuromuscular blockade should be reversed at the end ...
Eligibility Criteria
Inclusion
- 18-65 yr
- Body mass index 15.0-25.0 kg/m2
- American Society of Anesthesiologists physical status I-III
- Scheduled for elective surgery with an expected duration of more than 60 min under general anesthesia with endotracheal intubation
Exclusion
- Suspected difficulty airway
- Bronchial asthma, chronic obstructive pulmonary disease
- Neuromuscular disease
- Hepatic or renal dysfunction.
- Taking medications that might influence the effect of neuromuscular blocking agents
- Allergy to the medication that used in this trial
- Pregnant, or breastfeeding state
- Suspected malignant hyperthermia
- Contraindication to the medication that used in this trial
- Hypercalcemia
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT02213848
Start Date
August 1 2014
End Date
October 1 2014
Last Update
June 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 110-744